paracoccidioidomycosis
Jump to navigation
Jump to search
Epidemiology
- northeastern South America, Central America[3]
Clinical manifestations
- asymptomatic primary pulmonary infection, acute disseminated infection <10%[3]
Management
- itraconazole 100 mg PO QD
- amphotericin B 0.4-0.5 mg/kg/day IV
More general terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 851
- ↑ Jump up to: 3.0 3.1 3.2 NEJM Knowledge+